Zoetis (id:8528 ZTS)
176.96 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/25/2024 2:04:32 AM)
Exchange closed, opens in 7 hours 25 minutes
About Zoetis
Market Capitalization 78.79B
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
| Headquarters (address) |
10 Sylvan Way Parsippany 07054 NJ United States |
| Phone | 973 822 7000 |
| Website | https://www.zoetis.com |
| Employees | 14,100 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | ZTS |
| Exchange | New York Stock Exchange |
| Currency | USD |
| 52 week range | 144.80 - 201.92 |
| Market Capitalization | 78.79B |
| Dividend yield forward | 0.976 % |
| Dividend yield forward United States (ID:6, base:1863) | 4.13 % |
| P/E trailing | 32.89 |
| P/E forward | 27.54 |
| Price/Sale | 8.61 |
| Price/Book | 15.07 |
| Beta | 0.896 |
| EPS | 5.31 |
| EPS United States (ID:6, base:3415) | 24.13 |
Dividend growth streak
Zoetis has raised their dividend 10.00 years in a row. This is above the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Zoetis has raised their dividend 0.976 years in a row. This is below the 41491.801800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Zoetis has raised their dividend 23.31 years in a row. This is below the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Zoetis has raised their dividend 24.37 years in a row. This is above the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Zoetis has raised their dividend 22.63 years in a row. This is above the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Zoetis has raised their dividend 31.41 years in a row. This is below the 147.833000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Zoetis has raised their dividend 10.00 years in a row. This is above the 4.478450 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Zoetis has raised their dividend 0.976 years in a row. This is below the 41491.801800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Zoetis has raised their dividend 23.31 years in a row. This is below the 24.033000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Zoetis has raised their dividend 24.37 years in a row. This is above the 12.576000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Zoetis has raised their dividend 22.63 years in a row. This is above the 10.158800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Zoetis has raised their dividend 31.41 years in a row. This is below the 147.833000 year average in the 'Drug Manufacturers Specialty & Generic' industry